# Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

> **NCT03323346** · PHASE2 · RECRUITING · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 150 (estimated)

## Conditions studied

- Breast Neoplasm Female
- Metastatic Breast Cancer

## Interventions

- **DRUG:** Disulfiram

## Key facts

- **NCT ID:** NCT03323346
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-09-29
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03323346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03323346, "Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03323346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*